Sentinel lymph node detection in oral cancer: a within-patient comparison between [99mTc]Tc-tilmanocept and [99mTc]Tc-nanocolloid

Publication date

2021-03

Authors

den Toom, Inne J.
Mahieu, Rutger
van Rooij, RobISNI 000000039182607X
van Es, Robert J JISNI 0000000396355924
Hobbelink, M. G GISNI 000000039124351X
Krijger, Gerard C.ISNI 0000000052253975
Tijink, Bernard M
de Keizer, BartORCID 0000-0002-6270-9483ISNI 0000000393842428
de Bree, RemcoORCID 0000-0001-7128-5814ISNI 0000000387040744

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

Abstract

Purpose: Sentinel lymph node (SLN) biopsy has proven to reliably stage the clinically negative neck in early-stage oral squamous cell carcinoma (OSCC). [ 99mTc]Tc-tilmanocept may be of benefit in OSCC with complex lymphatic drainage patterns and close spatial relation to SLNs. Methods: A prospective within-patient evaluation study was designed to compare [ 99mTc]Tc-tilmanocept with [ 99mTc]Tc-nanocolloid for SLN detection. A total of 20 patients with early-stage OSCC were included, who underwent lymphoscintigraphy with both tracers. Both lymphoscintigraphic images of each patient were evaluated for SLN detection and radiotracer distribution at 2–4 h post-injection. Results: The injection site’s remaining radioactivity was significantly lower for [ 99mTc]Tc-tilmanocept (29.9%), compared with [ 99mTc]Tc-nanocolloid (60.9%; p < 0.001). Radioactive uptake in SLNs was significantly lower for [ 99mTc]Tc-tilmanocept (1.95%) compared with [ 99mTc]Tc-nanocolloid (3.16%; p = 0.010). No significant difference was seen in SLN to injection site ratio in radioactivity between [ 99mTc]Tc-tilmanocept (0.066) and [ 99mTc]Tc-nanocolloid (0.054; p = 0.232). A median of 3.0 and 2.5 SLNs were identified with [ 99mTc]Tc-tilmanocept and [ 99mTc]Tc-nanocolloid, respectively (p = 0.297). Radioactive uptake in higher echelon nodes was not significantly different between [ 99mTc]Tc-tilmanocept (0.57%) and [ 99mTc]Tc-nanocolloid (0.86%) (p = 0.052). A median of 2.0 and 2.5 higher echelon nodes was identified with [ 99mTc]Tc-tilmanocept and [ 99mTc]Tc-nanocolloid, respectively (p = 0.083). Conclusion: [ 99mTc]Tc-tilmanocept had a higher injection site clearance, but at the same time a lower uptake in the SLN, resulting in an SLN to injection site ratio, which was not significantly different from [ 99mTc]Tc-nanocolloid. The relatively low-radioactive uptake in SLNs of [ 99mTc]Tc-tilmanocept may limit intraoperative detection of SLNs, but can be overcome by a higher injection dose.

Keywords

Lymphatic metastasis, Lymphoscintigraphy, Oral cancer, Sentinel lymph nodes, [ Tc]Tc-tilmanocept, [Tc-99m]Tc-tilmanocept, Radiology Nuclear Medicine and imaging, Journal Article

Citation

den Toom, I J, Mahieu, R, van Rooij, R, van Es, R J J, Hobbelink, M G G, Krijger, G C, Tijink, B M, de Keizer, B & de Bree, R 2021, 'Sentinel lymph node detection in oral cancer : a within-patient comparison between [99mTc]Tc-tilmanocept and [99mTc]Tc-nanocolloid', European Journal of Nuclear Medicine and Molecular Imaging, vol. 48, no. 3, pp. 851-858. https://doi.org/10.1007/s00259-020-04984-8